Researchers in Queensland have found that the breast-milk protein osteopontin can protect infants against common respiratory infections [1].
This discovery provides a biological explanation for how breastfeeding supports the early immune system. Understanding the specific proteins involved may lead to new ways to protect vulnerable infants who cannot be breastfed.
The study was conducted by the QIMR Berghofer Medical Research Institute in Queensland, Australia [1]. The team said osteopontin is a critical component in the shield that protects newborns from deadly respiratory illnesses [2].
According to the research, osteopontin works by triggering immune-development pathways [2]. These pathways enhance the infant's natural resistance to various respiratory pathogens [1]. By activating these specific biological mechanisms, the protein helps the body recognize and fight off infections more effectively [2].
Respiratory infections remain a significant threat to infants due to their underdeveloped immune systems. The findings from the QIMR Berghofer Medical Research Institute highlight the complex interaction between maternal proteins and neonatal health [3].
The research suggests that the presence of osteopontin in breast milk serves as a primary defense mechanism, bridging the gap until the infant's own immune system fully matures [1].
“The breast-milk protein osteopontin can protect infants against common respiratory infections.”
The identification of osteopontin as a protective agent shifts the understanding of breast milk from a general source of nutrition to a targeted delivery system for immune-modulating proteins. This research could potentially pave the way for the development of synthetic supplements or therapeutic interventions for infants lacking access to breast milk, providing them with similar respiratory protection.
